eighteen patients with testicular cancer refractory to cisplatin , vinblastine and bleomycin ( pvb ) were treated with a non-cross-resistant regimen including adriamycin , 60 mg/m2 i.v . on day 1 , and vincristine , 1.2 mg/m2 i.v . on days 1 and 8 , alternated q 3 weeks with cyclophosphamide , 600 mg/m2 i.v . on days 1 and 8 , and actinomycin d , 1 mg/m2 i.v . on days 1 and 8 .
C0005740
bleomycin
C0072634
pvb